Bill > A01321

This bill amends the New York State education law to include nurse practitioners as providers who can engage in collaborative drug therapy management (CDTM), a process where pharmacists can help manage a patient's medication under a written agreement with a physician or nurse practitioner. The bill makes several key changes: it expands the definition of CDTM to include nurse practitioners alongside physicians, allowing pharmacists to adjust drug regimens, order certain laboratory tests, and perform patient monitoring functions within a predefined protocol. The bill also broadens the definition of "facility" to include up to fifteen community-practice sites where pharmacists and healthcare providers can establish collaborative arrangements. Pharmacists participating in CDTM must meet specific educational and experience requirements, such as having a master's or doctoral degree in pharmacy, maintaining an unrestricted license, and having at least two years of clinical experience. Importantly, the bill makes permanent the previous temporary authorization for pharmacists to perform CDTM, removes the previous sunset provision, and ensures that patient participation remains voluntary, with patients having the right to consent or opt out of the management at any time. The overall goal is to improve medication management and patient care by allowing pharmacists to work more closely with healthcare providers in managing drug therapies.

Education

https://www.nysenate.gov/legislation/bills/2025/A1321